Aptar Pharma Discusses Injectable Drug Delivery Partnering Considerations in ONdrugDelivery's May 2018 Issue

Once again putting forth its expertise in Injectable drug delivery, Aptar Pharma is featured in the May edition of ONdrugDelivery magazine. Entitled ‘Pharma Partnering Considerations for Injection Device Components’, this Expert View piece explores the key considerations Pharma companies should take into account for choosing the best possible...

Once again putting forth its expertise in Injectable drug delivery, Aptar Pharma is featured in the May edition of ONdrugDelivery magazine.

Entitled ‘Pharma Partnering Considerations for Injection Device Components’, this Expert View piece explores the key considerations Pharma companies should take into account for choosing the best possible partner to deliver and manufacture premium injectable components.

Written by Adam Shain, Director, Global Business Development, Injectables at Aptar Pharma, the feature highlights requirements that manufacturing partners should comply with to ensure that the resulting partnership will be symbiotic, mutually beneficial and ultimately deliver superior outcomes. Such requirements include quality assurance, consistency of supply and the sterilization of components.

Read the full article here: http://www.ondrugdelivery.com/publications/86/Aptar.pdf

Source: news.aptar.com